Founded in 1987, Natus has been a pioneer in advancing diagnostic and treatment solutions for central nervous system disorders. Since its inception, Natus has built a strong reputation for innovation in MedTech, continuously expanding its expertise and products portfolio.

In 2022, ARCHIMED recognized Natus‘ leadership in the field and supported a strategic transformation—splitting Natus into two specialized companies: Natus Sensory and Natus Neuro. This restructuring allows each company to focus on its unique mission and deepen its impact in its respective field.

Headquartered in Middleton, US, now operating as an independent company, Natus Neuro. The company provides cutting-edge hardware, software, algorithms, and disposable solutions to diagnose and monitor epilepsy and other neurological conditions across hospitals, intensive care units, and even at the patient’s home.